Rippert : Curriculum Vitae
Thèse et rapports
1.
Rippert P. Contribution à l’étude des préphénate/arogénate déshydrogénases de Synechocystis et d'Arabidopsis thaliana : caractérisation biochimique et moléculaire. Unité Mixte de Recherche CNRS/INRA/Bayer CropScience (UMR 1932): Université J. Fourier (Grenoble 1); 1999 Jun. (DEA de biologie cellulaire et moléculaire - 1998/1999). Report No.: Rapport de DEA.
2.
Rippert P. Caractérisation moléculaire et biochimique des préphénate et arogénate déshydrogénases d’Arabidopsis thaliana, de synechocystis et de levure [Thèse de doctorat]. [Grenoble, France]: Université Joseph Fourier; 2002.
Articles de Revues
1.
Delvert C, Rippert P, Margirier F, Vadot J-P, Bérard C, Poirot I, et al. Use and tolerability of a side pole static ankle foot orthosis in children with neurological disorders. Prosthet Orthot Int. 2016 May;
2.
Mouchoux C, Fassier T, Rippert P, Comet B, Castel-Kremer E, Barth X, et al. Nursing Staff Knowledge on Postoperative Delirium in Older Inpatients: An Exploratory Survey. Advanced Practices in Nursing [Internet]. 2015 Dec [cited 2016 Feb 1];2015(1):102. Available from: http://www.omicsonline.org/abstract-advanced-practices-nursing.php?abstract_id=66379
3.
Allard L, Rode G, Jacquin-Courtois S, Pouget MC, Rippert P, Hamroun D, et al. The motor function measure to study limitation of activity in children and adults with Charcot-Marie-Tooth disease. Annals of Physical and Rehabilitation Medicine [Internet]. 2014 Dec [cited 2014 Dec 9];57(9–10):587–99. Available from: http://www.sciencedirect.com/science/article/pii/S1877065714017825
4.
Vuillerot C, Meilleur KG, Jain M, Waite M, Wu T, Linton M, et al. English Cross-Cultural Translation and Validation of the Neuromuscular Score: A System for Motor Function Classification in Patients With Neuromuscular Diseases. Archives of Physical Medicine and Rehabilitation [Internet]. 2014 Nov [cited 2014 Oct 27];95(11):2064–70.e1. Available from: http://www.sciencedirect.com/science/article/pii/S0003999314003682
5.
Vuillerot C, Rippert P, Kinet V, Renders A, Jain M, Waite M, et al. Rasch Analysis of the Motor Function Measure in Patients With Congenital Muscle Dystrophy and Congenital Myopathy. Archives of Physical Medicine and Rehabilitation [Internet]. 2014 Nov [cited 2014 Oct 27];95(11):2086–95. Available from: http://www.sciencedirect.com/science/article/pii/S0003999314004365
6.
Vuillerot C, Braillon P, Fontaine-Carbonnel S, Rippert P, André E, Iwaz J, et al. Influence of a two-year steroid treatment on body composition as measured by dual X-ray absorptiometry in boys with Duchenne muscular dystrophy. Neuromuscul Disord. 2014 Jun;24(6):467–73.
7.
Mouchoux C, Rippert P, Duclos A, Fassier T, Bonnefoy M, Comte B, et al. Impact of a multifaceted program to prevent postoperative delirium in the elderly: the CONFUCIUS stepped wedge protocol. BMC Geriatr. 2011 May;11:25.
8.
Vuillerot C, Rippert P, Roche S, Bérard C, Margirier F, de Lattre C, et al. Development and validation of a motor function classification in patients with neuromuscular disease: The NM-Score. Annals of Physical and Rehabilitation Medicine [Internet]. 2013 Dec [cited 2013 Dec 9];56(9–10):673–86. Available from: http://www.sciencedirect.com/science/article/pii/S1877065713013092
9.
Ravanel S, Block MA, Rippert P, Jabrin S, Curien G, Rébeillé F, et al. Methionine metabolism in plants: chloroplasts are autonomous for de novo methionine synthesis and can import S-adenosylmethionine from the cytosol. J Biol Chem. 2004 May;279(21):22548–57.
10.
Rippert P, Matringe M. Purification and kinetic analysis of the two recombinant arogenate dehydrogenase isoforms of Arabidopsis thaliana. Eur J Biochem. 2002 Oct;269(19):4753–61.
11.
Rippert P, Puyaubert J, Grisollet D, Derrier L, Matringe M. Tyrosine and phenylalanine are synthesized within the plastids in Arabidopsis. Plant Physiol. 2009 Mar;149(3):1251–60.
12.
Rippert P, Matringe M. Molecular and biochemical characterization of an Arabidopsis thaliana arogenate dehydrogenase with two highly similar and active protein domains. Plant Mol Biol. 2002 Mar;48(4):361–8.
13.
Rippert P, Scimemi C, Dubald M, Matringe M. Engineering plant shikimate pathway for production of tocotrienol and improving herbicide resistance. Plant Physiol. 2004 Jan;134(1):92–100.
14.
Legrand P, Dumas R, Seux M, Rippert P, Ravelli R, Ferrer J-L, et al. Biochemical characterization and crystal structure of Synechocystis arogenate dehydrogenase provide insights into catalytic reaction. Structure. 2006 Apr;14(4):767–76.
15.
de Lattre C, Payan C, Vuillerot C, Rippert P, de Castro D, Bérard C, et al. Motor function measure: validation of a short form for young children with neuromuscular diseases. Arch Phys Med Rehabil. 2013 Nov;94(11):2218–26.
Brevets
1.
Matringe M, Rippert P. Novel Targets for Herbicides and Transgenic Plants Resistant to Said Herbicides [Internet]. WO/2002/046441, 2002 [cited 2013 Nov 5]. Available from: http://patentscope.wipo.int/search/en/detail.jsf?docId=WO2002046441&recNum=3&office=&queryString=FP%3A%28RIPPERT%2C+Pascal%29&prevFilter=&sortOption=Pub+Date+Desc&maxRec=3
2.
Matringe M, Rippert P, Dubald M, Dumas R. Transformed Plants with Enhanced Prenylquinone Biosynthesis [Internet]. WO/2004/024928, 2004 [cited 2013 Nov 5]. Available from: http://patentscope.wipo.int/search/en/WO2004024928
Prèsentations
1.
Rippert P. The SAS score: development and validation of content phase. Orale presented at: 31ème Congrès de la Société Française de Médecine Physique et de Réadaptation (SOFMER); 2016 Oct 15; Saint-Etienne, France.
2.
Rippert P. Etude de la sensibilité aux changements de la MFM dans la DM1. Orale presented at: 3ème réunion de l’observatoire national des dystrophies myotoniques, DM-Scope; 2016 10; Paris, France.
3.
Rippert P. Résultats préliminaires de la validation de la MFM dans les maladies congénitales du muscle. Oral presentation presented at: Réunion du Centre de référence neuromusculaire Rhône-alpes; 2013 Jun 6; Saint Etienne, France.
4.
Rippert P. The Motor Function Measure: responsiveness in SMA [Internet]. Oral presentation presented at: Workhop SMA EUROPE : Mapping out opportunities and challenges for SMA clinical trials; 2012 Jul 13–14; Rome, Italy. Available from: http://www.sma-europe.eu/news/1024/smae-s-workshop-highlights-and-report-on-mapping-out-opportunities-and-challenges-for-sma-clinical-trials-held-in-rome-italy-july-13e14-2012-are-now-available
5.
Rippert P. Arabidopsis thaliana arogenate dehydrogenase [Internet]. Poster presentation presented at: The 4th general meeting of the Société Française de Physiologie Végétale; 2000 Dec 5–7; Besançon, France. Available from: http://www.sudoc.abes.fr/DB=2.1//SRCH?IKT=12&TRM=152559973&COOKIE=U10178,Klecteurweb,D2.1,Eb519a8d4-886,I250,B341720009+,SY,A%5C9008+1,,J,H2-26,,29,,34,,39,,44,,49-50,,53-78,,80-87,NLECTEUR+PSI,R195.254.160.194,FN
6.
Rippert P. Identification and characteristaion of two isoforms of Arabidopsis thaliana arogenate dehydrogenase [Internet]. Poster presentation presented at: The 6th international symposium on inorganic nitrogen assimilation. From the field to the genome; 2001 Jul 8–12; Reims, France. Available from: http://www7.inra.fr/internet/Projets/reims2001/
7.
Rippert P. Comparative kinetic analyses of arogenate dehydrogenase from arabidopsis thaliana and Synechocystis and prephenate dehydrogenase from yeast [Internet]. Poster presentation presented at: The 6th international symposium on inorganic nitrogen assimilation. From the field to the genome; 2001 Jul 8–12; Reims, France. Available from: http://www7.inra.fr/internet/Projets/reims2001/
8.
Rippert P. Projet NM-Score : Construction et validation d’une classification en niveaux de sévérité d’atteinte fonctionnelle motrice dans le domaine des maladies neuromusculaires. Oral presentation presented at: Journée annuelle du Centre Maladies Neuromusculaires Rares Rhône-Alpes.; 2010 Jul 1; Saint-Etienne, France.
Participation à des présentations
1.
de lattre, Capucine. La Mesure de Fonction Motrice (MFM) dans la Dystrophie Facio-Scapulo-Humérale (FSHD) : description et sensibilité au changement. [Internet]. Orale et poster presented at: 31ème Congrès de la Société Française de Médecine Physique et de Réadaptation (SOFMER); 2016 Oct 13–15; Saint Etienne, France. Available from: http://saint-etienne.sofmer2016.com/
2.
Fontaine-Carbonnel S. 2005-2015 : expérience lyonnaise de dix ans de suivi du traitement corticostéroïde dans la Dystrophie Musculaire de Duchenne. [Internet]. Orale et poster presented at: 13-15 Octobre 2016, Saint Etienne. 31ème Congrès de la Société Française de Médecine Physique et de Réadaptation (SOFMER); 2016 Oct 13–15; Saint-Etienne, France. Available from: http://saint-etienne.sofmer2016.com/
3.
de lattre, Capucine. La Mesure de Fonction Motrice (MFM) dans la Dystrophie Myotonique de type 1 (DM1) : description et sensibilité au changement. [Internet]. Orale et poster presented at: 31ème Congrès de la Société Française de Médecine Physique et de Réadaptation (SOFMER); 2016 Oct 13–15; Saint Etienne, France. Available from: http://saint-etienne.sofmer2016.com/
4.
Schreiber-Bontemps A, Rivier F, Puy Haubert B, Ragot-Mandry S, Fournier-Mehouas M, Sacconi S, et al. Histoire naturelle des patients atteints de dystrophie musculaire de Duchenne, traités par corticothérapie, en comparaison aux patients non traités sur une période de 2 ans [Internet]. Poster presentation presented at: Congrès de la Société Française de Neurologie Pédiatrique (SFNP); 2016 Jan 20–22 [cited 2015 Jul 16]; Lille, France. Available from: http://www.sfneuroped.fr/nos-missions/congres-sfnp/
5.
Schreiber-Bontemps A, Rivier F, Puyhaubert B, Ragot-Mandry S, Fournier-Mehouas M, Sacconi S, et al. The natural history of Duchenne Muscular Dystrophy with corticosteroids using the Motor Function Measure [Internet]. Poster presentation presented at: 5th International Congress of Myology, Myology 2016; 2016 Mar 14–18 [cited 2015 Jul 16]; Lyon, France. Available from: http://www.myology2016.org/fr/
6.
Vuillerot C. English cross-cultural translation and validation of the NM-Score: a new system for motor function classification in patients with neuromuscular diseases [Internet]. Poster presentation presented at: 19th European Congress of physical and rehabilitation medicine and 29th Annual congress pf the French Society of physical and rehabilitation medicine (SOFMER); 2014 May 26–31; Marseille, France. Available from: http://www.esprm2014.com/abstract_display!en!!!!e50df9ce-aced-1031-ae0a-57176ee32719!6ddb9718-d014-1031-b196-61c1a3eebff0
7.
Vuillerot C. English cross-cultural translation and validation of NM-Score: a system for motor function classification in patients with neuromuscular diseases [Internet]. Poster presentation presented at: XIII International Congress on Neuromuscular Diseases (ICNMD XIII); 2014 Jul 5–10; Nice, France. Available from: http://icnmd2014.org/en/
8.
Schreiber-Bontemps A, Fournier-Mehouas M, Mahé J-Y, Tiffreau V, Lagrue E, Hamroun D, et al. Utilisation de la Mesure de Fonction Motrice pour étudier l’influence de la corticothérapie sur la fonction motrice chez des garçons atteints de Dystrophie Musculaire de Duchenne. [Internet]. Oral presentation presented at: 30ème Congrès MPR SOFMER; 2015 Oct 8–10 [cited 2015 Jul 16]; Montpellier, France. Available from: http://www.atout-org.com/sofmer2015/abstract_display!fr!!!!63710e1a-3040-1033-a713-1ad2d3a7cc08!53acd5b4-3f9e-1033-a713-1ad2d3a7cc08
9.
Vuillerot C. The Rasch-scaled MFM CDM: a Rasch Analysis Validation of the Motor Function Measure in Patients with Congenital Disorders of Muscle [Internet]. Poster presentation presented at: XIII International Congress on Neuromuscular Diseases (ICNMD XIII); 2014 Jul 5–10; Nice, France. Available from: http://icnmd2014.org/en/
10.
Vuillerot C. NM-Score: a new motor function classification for patients with neuromuscular diseases : inter-rater reliability study [Internet]. Poster presentation presented at: 4th International Congress of Myology; 2011 9–12; Lille, France. Available from: http://www.sfmyologie.org/index.php/journees-annuelles-sfm/jsfm-anterieures
11.
Allard L. The Motor Function Measure to study limitation of activity in children and adults patients with Charcot Marie Tooth (CMT) disease [Internet]. Poster presentation presented at: 19th European Congress of physical and rehabilitation medicine and 29th Annual congress pf the French Society of physical and rehabilitation medicine (SOFMER); 2014 May 26–31; Marseille, France. Available from: http://www.esprm2014.com/abstract_display!en!!!!cb6227da-acc9-1031-ae0a-57176ee32719!a81936b0-d014-1031-b196-61c1a3eebff0
12.
Vuillerot C. The Rasch-scaled MFM-CDM: a valid clinical outcome measure to assess functional ability of patients with congenital muscular dystrophy (CMD) [Internet]. Oral presentation presented at: 19th European Congress of physical and rehabilitation medicine and 29th Annual congress of the French Society of physical and rehabilitation medicine (SOFMER); 2014 May 26–31; Marseille, France. Available from: http://www.esprm2014.com/abstract_display!en!!!!c8b48190-ac2e-1031-ae0a-57176ee32719!6e7863d6-ca10-1031-b196-61c1a3eebff0
13.
Vuillerot C. Influence of a two-year steroid treatment on body composition as measured by Dual X-Ray Absorptiometry in boys with DMD [Internet]. Poster presentation presented at: XIII International Congress on Neuromuscular Diseases (ICNMD XIII); 2014 Jul 5–10; Nice, France. Available from: http://icnmd2014.org/en/
14.
Vuillerot C. Influence of a two-year steroid treatment on body composition as measured by Dual X-Ray Absorptiometry in boys with Duchenne Muscular Dystrophy (DMD) [Internet]. Oral presentation presented at: 19th European Congress of physical and rehabilitation medicine and 29th Annual congress pf the French Society of physical and rehabilitation medicine (SOFMER); 2014 May 26–31; Marseille, France. Available from: http://www.esprm2014.com/abstract_display!en!!!!e3339ec2-ac31-1031-ae0a-57176ee32719!6e7863d6-ca10-1031-b196-61c1a3eebff0
15.
Mouchoux C. Knowledge of nursing staff on postoperative delirium among elderly inpatients: results of a preliminary questionnaire survey [Internet]. Poster presentation presented at: 7th Congress of the EUGMS 2011; 2011 Sep 28–30; Malaga, Spain. Available from: http://www.sciencedirect.com/science/article/pii/S1878764911001112#
16.
Mouchoux C. Connaissances des soignants concernant le syndrome confusionnel postopér atoire de la personne âgée : résultats d’une enquête préliminaire [Internet]. Poster presentation presented at: 31èmes Journées annuelles de la société Française de gériatrie et gérontologie - JASFGG2011; 2011 Oct 4–6; Paris, France. Available from: http://www.jasfgg2011.com/download/JASFGG-Brochure.pdf
17.
Vuillerot C. The Rasch-scaled MFM-CDM: a valid clinical outcome measure to assess functional ability of patients with congenital muscular dystrophy. [Internet]. Oral presentation presented at: XIe Journées annuelles de la SFM - JSFM 2013; 2013 Nov 27–29; Montpellier, France. Available from: http://www.journees-sfm2013.fr/
18.
Wagschal I. Shikimate pathway in grapevine: influence in defence mechanisms against downy mildew? Poster presentation presented at: 5th D-BIOL Symposium ETH Zürich; 2004 May 19–21; Davos, Switzerland.
19.
Matringe M. Modulation of Vitamin E Biosynthesis in plants: importance of the regulation of the branch point between phenylalanine and tyrosine biosynthesis [Internet]. Oral presentation presented at: TERPNET 2007 - 8th International Meeting: Biosynthesis and Function of Isoprenoids in Plants, Microorganisms and Parasites; 2007 Apr 30–May4; Strasbourg, France. Available from: http://amds.u-strasbg.fr/depotcel/DepotCel/580/download/Abstract-BookTERPNET2007.pdf
20.
Matringe M. Modulation of Vitamin E Biosynthesis in planta: importance of the regulation of the branch point between phenylalanine and tyrosine biosynthesis. [Internet]. Poster presentation presented at: XV Congress of the FESPB; 2006 Jul 17–21; Lyon, France. Available from: http://www.fespb.org/fespb/content/fespb-congresses
21.
Mouchoux C. Etude CONFUCIUS: Impact d’un programme de prévention multidisciplinaire sur la survenue du syndrome confusionnel post-opératoire chez la personne âgée [Internet]. Poster presentation presented at: 9ème Congrès International Francophone de Gériatrie et Gérontologie (CIFGG); 2010 Oct 19–21; Nice, France. Available from: http://www.cifgg2010.com/
22.
Mouchoux C. Methodology for assessing the impact of a multidisciplinary prevention program to prevent postoperative delirium in the elderly [Internet]. Poster presentation presented at: 6th Congress of European Union Geriatric Medicine Society; 2010 Sep 29–Oct1; Dublin, Irleand. Available from: http://www.eugms.org/index.php/meetingscourses/15-pasteugmsmtgs
23.
Mouchoux C. Confucius study: impact of a multidisciplinary prevention program to prevent postoperative delirium in the elderly [Internet]. Poster presentation presented at: 27th International Conference of the International Society for Quality in Health Care; 2010 Oct 10–13; Paris, France. Available from: http://www.isqua.org/conference/previous-conferences/paris-2010
24.
Bérard C. Utilisation de la Mesure de Fonction Motrice (MFM-32) pour évaluer les capacités motrices des patients atteints d’Amyotrophie Spinale Infantile. Poster presentation presented at: 21ème congrès de la Société Française de Neurologie Pédiatrique; 2011 Jan 26–29; Lyon, France.
25.
Vuillerot C. NM-Score: a new motor function classification for patients with neuromuscular diseases : validation study against criteria [Internet]. Poster presentation presented at: Xèmes journées annuelles de la Société Française de Myologie; 2012 Nov 14–16; Grenoble, France. Available from: http://www.sfmyologie.org/index.php/journees-annuelles-sfm/jsfm-anterieures
26.
Vuillerot C. A cross sectional validation study of the English version of the NM-Score in patients with neuromuscular diseases [Internet]. Poster presentation presented at: 18th International WMS Congress; 2013 Oct 1–5 [cited 2013 Nov 5]; Asilomar, California, USA. Available from: http://www.sciencedirect.com/science/article/pii/S096089661300713X
27.
Vuillerot C, Rippert P, Jain M, Waite M, Glanzman A, Kinet V, et al. The Rasch-scaled motor function measure for patients with congenital disorders of muscle [Internet]. Poster presentation presented at: 18th International WMS Congress; 2013 Oct 1–5 [cited 2013 Nov 5]; Asilomar, California, USA. Available from: http://www.sciencedirect.com/science/article/pii/S0960896613007141
Articles de colloque
1.
Carbonnel SF, Rippert P, Poirot I, Gachet D, de Lattre C, Vuillerot C. 2005–2015: Ten years clinical experience in treating DMD patients by corticosteroids in Lyon. Annals of Physical and Rehabilitation Medicine [Internet]. 2016 [cited 2016 Sep 27];59:e82. Available from: http://www.sciencedirect.com/science/article/pii/S1877065716302688
2.
de Lattre C, Rippert P, Hmaroun D, Sacconi S, Poirot I, Vuillerot C. The motor function measure (MFM) in the facio scapulo humeral dystrophy (FSHD) population: Description and responsiveness. Annals of Physical and Rehabilitation Medicine [Internet]. 2016 [cited 2016 Sep 27];59:e84–5. Available from: http://www.sciencedirect.com/science/article/pii/S1877065716302755
3.
de Lattre C, Rippert P, Bassez G, Hamroun D, Poirot I, Vuillerot C. The motor function measure (MFM) in the myotonic dystrophy type 1 population: Description and responsiveness. Annals of Physical and Rehabilitation Medicine [Internet]. 2016 [cited 2016 Sep 27];59:e81. Available from: http://www.sciencedirect.com/science/article/pii/S1877065716302664
4.
Schreiber-Bontemps A, Brochard S, Fontaine-Carbonnel S, Chabrier S, Gautheron V, Peudenier S, et al. Promoting the use of Motor Function Measure (MFM) as outcome measure in patients with Duchenne Muscular Dystrophy (DMD) treated by corticosteroids. Annals of Physical and Rehabilitation Medicine [Internet]. 2015 Sep [cited 2015 Oct 13];58, Supplement 1:e139–40. Available from: http://www.sciencedirect.com/science/article/pii/S1877065715004145
5.
Vuillerot C, Braillon P, Fontaine-Carbonnel S, Rippert P, Andre E, Iwaz J, et al. T.P.44: Influence of a two-year steroid treatment on body composition as measured by Dual X-ray Absorptiometry in boys with Duchenne Muscular Dystrophy. Neuromuscular Disorders [Internet]. 2014 Oct [cited 2014 Sep 15];24(9–10):907. Available from: http://www.sciencedirect.com/science/article/pii/S0960896614005264
6.
Vuillerot C, Rippert P, Jain M, Waite M, Glanzman A, Kinet V, et al. P.10.10 The Rasch-scaled motor function measure for patients with congenital disorders of muscle. Neuromuscular Disorders [Internet]. 2013 Oct [cited 2014 Jul 7];23(9–10):791–2. Available from: http://www.sciencedirect.com/science/article/pii/S0960896613007141
7.
Vuillerot C, Rippert P, Berard C, Bonnemann C, Meilleur K, Jain M, et al. P.10.9 A cross sectional validation study of the English version of the NM-Score in patients with neuromuscular diseases. Neuromuscular Disorders [Internet]. 2013 Oct [cited 2014 Jul 7];23(9–10):791. Available from: http://www.sciencedirect.com/science/article/pii/S096089661300713X
8.
Vuillerot C, Rippert P, Kinet V, Renders A, Jain M, Waite M, et al. Rasch analysis of the motor function measure in patients with congenital muscle dystrophy and congenital myopathy. Annals of Physical and Rehabilitation Medicine [Internet]. 2014 May [cited 2014 Jun 5];57, Supplement 1:e97. Available from: http://www.sciencedirect.com/science/article/pii/S1877065714003753
9.
Vuillerot C, Braillon P, Fontaine-Carbonnel S, Rippert P, Andre E, Iwaz J, et al. Influence of a 2-year steroid treatment on body composition as measured by dual X-ray absorptiometry in boys with Duchenne muscular dystrophy. Annals of Physical and Rehabilitation Medicine [Internet]. 2014 May [cited 2014 Jun 5];57, Supplement 1:e98. Available from: http://www.sciencedirect.com/science/article/pii/S1877065714003765
10.
Allard L, Rode G, Luaute J, Jacquin-Courtois S, Rippert P, Hamroun D, et al. The motor function measure to study limitation of activity in children and adults patients with Charcot-Marie-Tooth disease. Annals of Physical and Rehabilitation Medicine [Internet]. 2014 May [cited 2014 Jun 5];57, Supplement 1:e103–4. Available from: http://www.sciencedirect.com/science/article/pii/S187706571400400X
11.
Vuillerot C, Meilleur KG, Jain M, Waite M, Wu T, Dastgir J, et al. English cross-cultural translation and validation of the NM-Score: A system for motor function classification in patients with neuromuscular diseases. Annals of Physical and Rehabilitation Medicine [Internet]. 2014 May [cited 2014 Jun 5];57, Supplement 1:e105. Available from: http://www.sciencedirect.com/science/article/pii/S1877065714004047
12.
Mouchoux C, Duclos A, Rippert P, Colin C. Étude CONFUCIUS : impact d’un programme de prévention multidisciplinaire sur la survenue du syndrome confusionnel postopératoire chez la personne âgée. In Nice, France: Springer; 2010. p. 303–27. (cah. année gerontol.; vol. 2.3). Available from: http://download.springer.com/static/pdf/408/art%253A10.1007%252Fs12612-010-0085-x.pdf?auth66=1383839321_2b8b35530de8f1df6c5274604ad6b5e8&ext=.pdf
13.
Société française de physiologie végétale. Colloque général. Plant sciences for the third millenium: Abstracts of symposia and poster presentations of Plant sciences for the third millenium. In: Société française de physiologie végétale, editor. Besançon, France: Société française de physiologie végétale : Université de Franche-Comté; 2000. p. 197.
Rapports d'étudiants encadrés
1.
Scimemi C. Contribution à l’étude de la préphénate déshydrogénase de levure et obtention de plantes transgéniques enrichies en prénylquinones. Dijon: Université de Bourgogne; 2000 Jun. Report No.: Rapport de stage Diplôme Supérieur d’Etude et de Recherche.
2.
Derrier L. Contribution à l’étude de l'arogénate déshydrogénase d'Arabidopsis thaliana : Etude de l'expression des ARNm codant les deux isoformes d'arogénate déshydrogénase d'Arabidopsis thaliana. Unité Mixte de Recherche CNRS/INRA/Bayer CropScience (UMR 1932): Institut National des Sciences Appliquées de Lyon; 2002 Sep. Report No.: Rapport de stage de fin d’études - Institut National des Sciences Appliquées de Lyon.
Enregistrement d'études cliniques
1.
Bergeret A. NCT00782925 : PRESLO Study : An Educational and Exercise Program as Secondary Prevention of Recurrent Lower Back Pain in Healthcare Workers - ClinicalTrials.gov [Internet]. 2008 [cited 2013 Nov 5]. Available from: http://clinicaltrials.gov/ct2/show/NCT00782925?term=preslo&rank=1
2.
Krolak-Salmon P. NCT01316965 : CONFUCIUS Study : Impact of a Multifaceted Program to Prevent Postoperative Delirium in the Elderly - ClinicalTrials.gov [Internet]. 2011 [cited 2013 Nov 5]. Available from: http://clinicaltrials.gov/ct2/show/NCT01316965?term=confucius&rank=1
3.
Comte B. NCT01947270 : OPMED Study : Multidisciplinary Program “Optimization of Drug Prescription” : Impact on the Quality of Drug Prescription in Hospitalized Elderly Patients - ClinicalTrials.gov [Internet]. 2013 [cited 2013 Nov 5]. Available from: http://clinicaltrials.gov/ct2/show/record/NCT01947270?term=opmed&rank=1

Upgrade Storage